About Dr. Azriel Hirschfeld | Hirschfeld Oncology
With over 15 years of experience as a board-certified oncologist, Dr. Hirschfeld has dedicated his career to pushing the boundaries of cancer therapy.
When facing cancer, many patients trust their oncologists at big academic institutions to provide the most advanced treatments available. However, for aggressive cancers like bile duct, ovarian, pancreatic, and triple-negative breast cancer, standard treatments often fall short as the cancer becomes more resistant. At this critical juncture, many doctors may feel there is nothing more they can do, sometimes discouraging further treatment due to perceived limited benefits and impact on quality of life.
Dr. Hirschfeld is highly skilled in administering standard cancer treatments, but his true expertise lies in tackling aggressive, mutating cancers that don’t respond to conventional methods. Many patients don’t realize that alternative options exist until they meet Dr. Hirschfeld. Often, they come to him after their primary oncologists have recommended hospice care following multiple failed treatments. These patients, even those from leading academic institutions, often have complex medical histories that deter other doctors from taking their cases.
Dr. Hirschfeld meticulously reviews each patient’s medical history to develop a tailored treatment plan that may include immunotherapies, multi-drug low dose regimens, off-label drug treatments, supplements, and participation in clinical trials. He employs sophisticated methods such as monitoring patients with cell-free DNA, also known as “liquid biopsies,” to track progress in real-time. This allows for immediate adjustments to treatments based on both tolerability and effectiveness, rather than waiting two or three months for repeat imaging.
At Hirschfeld Oncology our approach goes beyond offering empty promises; it’s rooted in delivering real, scientifically-backed solutions that genuinely restore hope. By employing innovative drug combinations and re-partnering previously unsuccessful treatments, Dr. Hirschfeld has helped countless patients achieve remarkable outcomes. Dr. Hirschfeld has proven results that offer a new level of hope and care, making a tangible difference in the lives of those he treats.
Combination chemotherapy is the use of more than one medication at a time to treat cancer. Since chemotherapy drugs affect cancer cells at different points in the cell cycle, using a combination of drugs increases the chance that all of the cancer cells will be eliminated.
With over 15 years of experience as a board-certified oncologist, Dr. Hirschfeld has dedicated his career to pushing the boundaries of cancer therapy.
Targeted therapies specifically targets the unique characteristics of cancer cells. Advancements Stage 4 Colorectal Cancer Treatments
Supporting Stage 4 Cancer Patient Families | Hirschfeld Oncology Bushwick, Brooklyn, New York City. Cancer Infusion Center
Metastatic Gastric Cancer: Low-dose Chemotherapy Led to Remission. Innovative, forward thinking, Hirschfeld Oncology.
Ruby recounts her journey with intrahepatic cholangiocarcinoma, a rare bile duct cancer. Hirschfeld Oncology, New York.
This is an interview with Sarah’s husband Bill, about her battle against stage 4 colon cancer told in a series of short interview episodes.
Tolerability and Efficacy of Alternative Cancer Therapy Treatment. Metastatic pancreatic cancer with comorbidities. Less toxic regimen.
Unique Clinical Experience Gives Patient Another Chance When Options Seemed Exhausted. Hirschfeld Oncology Case Study.
A 67 year-old Caucasian female with a history of: pheochromocytoma (cancer of the adrenal gland). Hirschfeld Oncology Williamsburg New York.